APA

Sharma A., Hafeez Faridi M., Kumar N., Parachuri N., Sharma R., Kuppermann B. D., Bandello F., Loewenstein A. & Regillo C. D. (20210618). Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. : Eye (London, England).

Chicago

Sharma Ashish, Hafeez Faridi M, Kumar Nilesh, Parachuri Nikulaa, Sharma Rohini, Kuppermann Baruch D, Bandello Francesco, Loewenstein Anat and Regillo Carl D. 20210618. Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. : Eye (London, England).

Harvard

Sharma A., Hafeez Faridi M., Kumar N., Parachuri N., Sharma R., Kuppermann B. D., Bandello F., Loewenstein A. and Regillo C. D. (20210618). Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. : Eye (London, England).

MLA

Sharma Ashish, Hafeez Faridi M, Kumar Nilesh, Parachuri Nikulaa, Sharma Rohini, Kuppermann Baruch D, Bandello Francesco, Loewenstein Anat and Regillo Carl D. Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. : Eye (London, England). 20210618.